Skip to main content

EAN 2024

EAN 2024 Congress

29 June–2 July 2024 | Helsinki

The European Academy of Neurology's 10th annual congress focused on neuromodulation: advances and opportunities in neurological diseases. Leading specialists tackled hot topics across neurology, including the latest developments in movement disorders, epilepsy, multiple sclerosis, headache, autonomic nervous system diseases, and dementia. We bring you the latest news from the congress.

08-07-2024 Huntington's Disease News

Pridopidine benefits HD patients not taking antidopaminergics

Pridopidine improves function, motor, and cognitive outcomes in patients with Huntington’s disease who are not taking antidopaminergic medications.

Fremanezumab offers sustained reduction in migraine

15-07-2024 Migraine News

Switching to fremanezumab from another type of calcitonin gene-related peptide pathway agent achieves a significant reduction in monthly migraine days.

Frexalimab sustains efficacy in MS

11-07-2024 Multiple Sclerosis News

The anti-CD40L monoclonal antibody frexalimab shows sustained benefit over 48 weeks in patients with relapsing multiple sclerosis.

NEOS2 score predicts anti-NMDAR encephalitis outcomes

Researchers have developed the anti-NMDAR Encephalitis One-Year Functional Status 2 score for predicting short- and long-term outcomes at the point of diagnosis.

Anti-AMPAR encephalitis manifests differently in children versus adults

Clinical characteristics of anti-AMPAR encephalitis in children include prodromal symptoms, movement disorders, and cerebellar symptoms.

Neurology Update

Covering the latest advances and keeping your practice up to date. Receive newsletters personally curated for the busy neurologist.

Exercise and ketogenic diet reduce daytime sleepiness

04-07-2024 Narcolepsy News

Regular exercise and a ketogenic diet are effective in treating daytime sleepiness in patients with narcolepsy. 

Cumulative opioid use is associated with greater risk of dementia

04-07-2024 Dementia News

High cumulative opioid use may increase the risk of dementia before the age of 90 years.

Speed of changes in ALS symptoms correlates with survival

Degree of change in disease burden between symptom onset and initial clinical evaluation could better predict prognosis in amyotrophic lateral sclerosis.

Brain biopsy useful for unexplained neurological disorders

Brain biopsy may be a safe and viable diagnostic procedure for unexplained neurological disorders of the CNS.

04-07-2024 Multiple Sclerosis News

Parental smoking linked to increased MS risk

Selective exposure to parental smoking at a young age may differentially increase an individual’s risk for developing pediatric- and adult-onset multiple sclerosis.

Tilted sleeping may reduce blood pressure in PD

02-07-2024 Parkinson's Disease News

Tilted sleeping may help to reduce nocturnal hypertension in some patients with Parkinson's disease or parkinsonism.

Healthcare systems not ready for AD treatments

02-07-2024 Alzheimer's Disease News

Changes to European healthcare systems will be needed if monoclonal antibodies are approved for the treatment of Alzheimer's disease.

Ocrelizumab effective as long-term treatment for relapsing MS

02-07-2024 Multiple Sclerosis News

An analysis of real-world data has found ocrelizumab to be an effective long-term treatment for relapsing multiple sclerosis.

Men with cluster headaches more likely to have compensated hypogonadism

02-07-2024 Cluster Headache News

Compensated hypogonadism in men with cluster headache indicates the androgen system plays a pathophysiological role.

People with epilepsy face difficulties in employment

02-07-2024 Epilepsy News

People with epilepsy may have difficulty finding and retaining a job, with several factors impacting employment.

Ethnicity influences access to care for acute cerebral infarction

02-07-2024 Stroke News

Patient ethnicity may affect access to reperfusion therapy for cerebral infarction in European countries.  

02-07-2024 Alzheimer's Disease News

Vagal nerve stimulation during sleep: new cognition aid?

Non-invasive vagal nerve stimulation applied at night may improve cognition in patients with mild cognitive impairment due to Alzheimer’s disease.

Stay up to date with more from Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Webinar | 02-05-2024 | 17:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.

Dr. Rolf Fronczek
Dr. Renata Riha
Dr. Sven Rupprecht
Developed by: Springer Medicine

Advances in Alzheimer's

Alzheimer's Disease Independent Medical Education

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by: Lilly

Developed by: Springer Healthcare IME

Parkinson’s disease guidelines

Open Access Parkinson's Disease Guideline

Latest advice from DGN, in collaboration with ÖGN and SNG, on diagnostics, pharmacotherapy, and invasive treatment options to manage motor and non-motor symptoms.